An analysis of vaccinated populations: Mortality rates and adverse event episodes

The purpose of the present study is to determine the mortality rate for COVID-19 vaccines in the United States, using the Vaccine Adverse Event Reporting System (VAERS) as the primary data source. In addition, regression analysis was used to estimate the factors that may affect the reported number of days from vaccination to onset of symptoms due to vaccine complications and the reported number of days from vaccination until death. It was estimated that the crude mortality rate for all COVID-19 vaccines was 6.3 deaths per 100,000 vaccinated persons for the period December 14, 2020 to December 31, 2023. If one examines only those deaths that occurred with 60 days of vaccination, the crude mortality rate was 3.24 deaths per 100,000 persons for the period in question. This mortality rate is substantially lower than the crude mortality rate for non-COVID-19 vaccines estimated in McCarthy et al. (2013) which was 608 deaths per 100,000 persons. In addition, the mean number of days from vaccination to onset of symptoms and from vaccination to death increased dramatically once the COVID-19 vaccines became available. This includes the means for non-COVID vaccines as well.